Introduction
IkBa inhibits the transcription factor NFkB by retaining it in the cytosol. Following exposure to a variety of stimuli (reviewed in Baeuerle and Henkel, 1994) , IkBa is degraded via ubiquitin-mediated proteolysis freeing NFkB to enter the nucleus and transcribe genes involved in in¯ammatory responses and cellular stress. The pre-requisite to IkBa ubiquitination and degradation is the activation of the IkB speci®c kinase, IKK, which phosphorylates IkBa on serines 32 and 36 allowing it to be recognized by a speci®c E3 ligase. In this process, ubiquitin (8.5 kD) is accepted by the E1 activating enzyme in an ATP dependent reaction forming a thiolester intermediate between the active site cysteine of E1 and the carboxy-terminal glycine of ubiquitin. E1 transfers ubiquitin to a family of ubiquitin conjugating enzymes (Ubc) via a thiolester intermediate. The Ubc then associates with an E3 ligase, the activity of which leads to the formation of a poly-ubiquitin chain on a lysine of the target protein.
These poly-ubiquitinated proteins are then degraded by the 26S proteasome.
Two classes of E3 ligases can be distinguished based on their ability to form thiolester intermediates. The HECT family of E3 ligases, of which E6-AP is the prototype, contains an active site cysteine and directly accept ubiquitin from the Ubc forming a thiolester intermediate before coupling it to the target substrate. Other E3 ligases such as the anaphase promoting complex (APC), VHL complexes and SCF complexes are thought to act as substrate recognition domains bringing a Ubc together with the target protein (reviewed in Tyers and Willems, 1999) . The IkBa E3 ligase has been shown to contain the F-box protein b-TRCP (Yaron et al., 1998; Winston et al., 1999; Spencer et al., 1999; Suzuki et al., 1999; Fuchs et al., 1999; Kroll et al., 1999; Hatakeyama et al., 1999) and has been identi®ed as SCF b-TRCP consisting of Skp1, Cul1 and the F-box protein b-TRCP (Winston et al., 1999; Spencer et al., 1999; Suzuki et al., 1999; Hatakeyama et al., 1999 ). An additional component of SCF complex has recently been identi®ed as Rbx1 . Rbx1 (or ROC1 or Hrt1 (Seol et al., 1999) ) has been shown to be required for G1 cyclin , Sic1 Seol et al., 1999) and IkBa ubiquitination (Tan et al., 1999; Ohta et al., 1999) . b-TRCP has also been shown to be responsible for ubiquitination of b-catenin (Winston et al., 1999; Fuchs et al., 1999; Latres et al., 1999; Kitagawa et al., 1999; Hart et al., 1999) CD4 via the associated HIV protein VPU (Margottin et al., 1998) and based on genetic studies in Drosophila (Jiang and Struhl et al., 1998) suggested to be involved in processing of Cubitus interruptus (Ci) (Winston et al., 1999; Spencer et al., 1999; reviewed in Maniatis, 1999) . The common determinant for ubiquitination of these proteins is recognition of their double phosphoserine sequence motifs by the F-box protein b-TRCP of the SCF b-TRCP complex (reviewed in Laney and Hochstrasser, 1999 contained Skp1, Cul1, b-TRCP and Rbx1 (Figure 1a ). Multiple species of Cul1 observed in the THP.1 extracts are likely due to Nedd8 modi®cation, recently shown to be important in ubiquitination of IkBa (Read et al., 2000) . This is supported by the observation that the majority of the Cul1 present in the Q 0.4 M elute, containing the IkBa ubiquitinating activity, consisted mainly of a higher M r form of Cul1 ( Figure 1a , lane 3). The Q unbound or Q 0.4 M SCF b-TRCP fractions individually lacked IkBa ubiquitinating activity, however, in combination the phosphorylation dependent IkBa ubiquitinating activity observed in the starting THP.1 extract was restored (Figure 1b) . The ubiquitinated IkBa observed with the Q unbound alone (lane 6) was not inhibited by phospho-IkBa (aa23 ± 41) peptide nor methylated-ubiquitin (not shown) and therefore represents non-speci®c mono-ubiquitinated IkBa instead of phosphorylation dependent polyubiquitinated IkBa. This mono-ubiquitination was not observed with the unphosphorylated IkBa complex (lane 5) and may represent a conformational change in the IkBa upon phosphorylation.
Standard chromatographic techniques were employed to purify the Q unbound activity to near homogeneity (Figure 1c ). The ®nal step, which utilized a mono S column, identi®ed two protein bands (*10 and 17 kD) in fraction 23 (Figure 1c , middle) which correlated with reconstitution of IkBa ubiquitinating activity (Figure 1c, top) . Sequence analysis of the 17 kD band identi®ed several peptides corresponding to amino acids 6 ± 15 of the Ubc 4/5 family. The identities of amino acids 7 and 11 allowed us to distinguish this speci®cally as Ubc4 , also known as Ubc5B (Jensen et al., 1995) (Figure 1d ). Immunoblots of the mono S column fractions with antiserum to Ubc4 also identi®ed this protein in fractions 22 ± 23 and show a positive correlation between Ubc4 concentration and IkBa ubiquitinating activity (Figure 1c, bottom) . Peptide sequencing identi®ed the 10 kD band in fraction 23 as keratin 9 (data not shown).
SCF
b-TRCP reconstitution and specificity Supporting the conclusion that Ubc4 is the active protein in the Q unbound fraction, we found that this fraction could be replaced by recombinant Ubc4 to drive IkBa/p50/p65 ubiquitination in a reconstituted system containing SCF b-TRCP ( Figure 2a , lanes 2 and 6). This reaction was phosphorylation dependent (compare lanes 6 and 7) but was not dependent on the addition of recombinant Skp1 (Figure 2b ) or the recently described Cul1 interacting protein Rbx1/ ROC1/Hrt1 Kamura et al., 1999; Seol et al., 1999; Ohta et al., 1999; Latres et al., 1999) suggesting that insect cell Skp1 and Rbx1 were co-purifying with GST-b-TRCP or His-Cul1. This conclusion was con®rmed by immunoblotting the recombinant SCF components with antibodies speci®c to Skp1 and Rbx1 (Figure 2c ). Anti-Skp1 immunoblots show that Skp1 was associated with both the Fbox proteins GST-b-TRCP and GST-Skp2 (lanes 1 and 2) and also with His-Cul1 (lane 3). Anti-Rbx1 immunoblots reveal that it is associated speci®cally with His-Cul1 (Figure 2c , lane 3) but not with the Fbox proteins or interestingly with His-Cul3 (lanes 1, 2 and 4). To demonstrate that IkBa ubiquitination was speci®c for the recombinant SCF b-TRCP complex, GSTb-TRCP was replaced with an alternative F-box protein, GST-Skp2 and His-Cul1 with His-Cul3. Neither the GST-Skp2/His-Cul1 nor GST-b-TRCP/ His-Cul3 complex was found to promote the ubiquitination of phosphorylated-IkBa/p50/p65 (Figure 2d ). Consistent with this ®nding, is the fact that SCF complexes have so far only been reconstituted with Cdc53 in S. cerevisiae (Skowyra et al., 1997; Feldman et al., 1997 (Cdc53 is the ortholog of Cul1) or with Cul1 in mammalian systems (Michel and Xiong, 1998). As mentioned above, GST-Skp2 and GST-b-TRCP are associated with insect cell Skp1 whereas Rbx1 was only found associated with His-Cull ( Figure  2c ). The lack of activity in the His-Cul3/GST-b-TRCP containing reaction is therefore most likely explained by the lack of Rbx1. This ®nding suggests that Cul3 does not readily associate with Rbx1 or that it functions through a dierent ring ®nger protein.
Ubc specificity for IkBa ubiquitination by SCF b-TRCP
Having established an in vitro system that was dependent on recombinant ubiquitination components we wished to address the issue of Ubc speci®city. SCF complexes are best characterized in the yeast, S. cerevisiae where a single Ubc, Ubc3/Cdc34 mediates ubiquitination of a variety of SCF targeted substrates (reviewed in Elledge and Harper, 1998). However, a human Ubc4/5 homolog has been reported to enhance the in vitro ubiquitination of IkBa (Chen et al., 1996; Yaron et al., 1998; Fuchs et al., 1999; Kroll et al., 1999) . We expressed and puri®ed eight dierent human ubiquitin conjugating enzymes and assessed their ability to support phosphorylation dependent IkBa/p50/p65 ubiquitination in our in vitro system (Figure 3, top) . Each human Ubc was shown to be active by its ability to be charged by human E1 as demonstrated by the formation of ubiquitin-Ubc thiolesters (Figure 3, bottom) . Multiple ubiquitinUbc bands observed with Ubc2, 3, 10, epi are due to Ub chain formation. Several of the lower M r bands observed with Ubc3 are believed to be Ubc3 degradation products capable of being charged by E1. In this experiment the Ubcs were normalized for protein concentration and not activity, however, the data in Figure 3 clearly show that Ubc4 is as active as Ubc 7 and 8 and yet the latter two are incapable of catalyzing the transfer of ubiquitin to IkBa. Only Ubc3 and Ubc4 could support phosphorylation dependent ubiquitination of IkBa. Ubc3 was not originally identi®ed as an active component of the IkBa ubiquitinating activity from the THP.1 lysate because it is not present in the Q unbound fraction or the 0.4 M eluate due to its elution at *0.5 M KCl from the Q resin (data not shown). The low level ubiquitination by Ubc10 seen in Figure 3 , top, was not phosphorylation dependent (data not shown).
The Ubc transfers ubiquitin directly to IkBa
Ubiquitin ligases can be broadly characterized into two mechanistically distinct groups: those that act catalytically via a thiolester cascade (exempli®ed by the HECT protein E6AP) Huibregtse et al., 1995) and those that mediate substrate recognition (exempli®ed by SCF's in yeast) (reviewed in Elledge and Harper, 1998; Koepp et al., 1999) . We wished to determine whether the SCF b-TRCP complex contained any thiol groups that were important for catalysis. It has previously been shown that mutation of the single cysteine of Skp1 and the six cysteines of Cdc53, the yeast Cul1 ortholog, had no eect on the thiolester transfer of ubiquitin to target substrates (Skowyra et al., 1997) . It is not known, however, whether F-box proteins or other associated proteins (such as Rbx1), are involved in a thiol ester transfer cascade. To address this, the recombinant GST-b-TRCP/Skp1 or His-Cul1/Rbx1 proteins were individually treated with NEM to covalently modify reactive thiols; excess NEM was then scavenged with DTT. The NEM treated proteins were then used in in vitro ubiquitination reactions (Figure 4) . In multiple experiments, NEM had little or no eect on GST-b-TRCP/Skp1 and HisCul1/Rbx1 (Figure 4, lanes 2 and 3) . NEM treatment of the combined ubiquitination components (GST-b-TRCP/Skp1, His-Cul1/Rbx1 and Ubc3) did, however, prevent IkBa ubiquitination (Figure 4, lane 4) . This demonstrated that the NEM treatment was capable of inactivating a thiol sensitive component (Ubc3) when present. Addition of untreated Ubc3 to the NEM treated components (GST-b-TRCP/Skp1, His-Cul1/ Rbx1 and Ubc3) restored activity (Figure 4, lane 5) . . Top panel, ubiquitination of IkBa was carried out as described in the Materials and methods with assays containing E1 (0.5 mM), Ubc (1.5 mM), His-Cul1 (16 nM), GST-b-TRCP (50 nM). Lower panel, Ubcs added were active as demonstrated by their ability to accept ubiquitin from E1. Bands observed are ubiquitin-Ubc thiolester intermediates identi®ed as previously described in the absence of SCF b-TRCP and IkBa Similar results were obtained using Ubc4, however, they were not as clear or dramatic due to the fact that complete inactivation of Ubc4 by NEM was dicult to achieve and the residual activity could promote IkBa ubiquitination (data not shown). These results lend strong support to the notion that ubiquitin is donated to IkBa directly by the ubiquitin conjugating enzyme (Ubc) and that the SCF provides the phosphosubstrate recognition function. These results are in agreement with the recent work of Seol et al. (1999) showing that the SCF Cdc4 complex is refractory to inactivation by NEM treatment.
Ubc3 and Ubc4 associate with SCF b-TRCP in THP.1 extracts
We have demonstrated that Ubc3 and Ubc4 can polyubiquitinate IkBa/p50/p65 in the presence of the E3 ligase SCF b-TRCP in vitro. It will be important to understand what role these Ubcs play in IkBa ubiquitination in vivo. In order to determine whether Ubc3 and Ubc4 from human cells associate with the endogenous SCF b-TRCP complex we incubated THP.1 cell lysates with the phospho-IkBa-p19 peptide sepharose ( Figure 5, lane 1) or the non-phosphorylated serine to alanine control peptide sepharose (lane 2). Peptide associated proteins were recovered and analysed by immunoblotting. As expected, b-TRCP associated with the peptide sepharose in a phosphorylation dependent manner. Figure 5 demonstrates the association of both Ubc3 and Ubc4 with the phospho-peptide (lane 1) with little or no binding to the control peptide (lane 2). Ubc2, also present in the THP.1 extracts (lane 3) and shown in the in vitro reconstitution reactions to not be involved in IkBa poly-ubiquitination, did not associate with either peptide sepharose. We estimate that only a very small amount of Ubc3 and 4 was associated with the SCF b-TRCP -phospho-peptide sepharose since longer exposures were required to detect these proteins compared to the amount present in the starting extract.
The antibodies used only reacted with the speci®c Ubc when compared to the panel of proteins listed in Figure 3 (not shown). Immunoblots of recombinant His-tagged Ubcs demonstrate that the various antibodies display similar immunoreactivity with their cognate Ubc ( Figure 5 , lanes 4 ± 5) with the Ubc4 antibody producing the weakest signal. These results also suggest that Ubc3 is less abundant than Ubc2 or 4 in THP.1 extracts. In addition, results of the puri®cation of the Q unbound also suggest that Ubc4 is the predominant Ubc4/5 family member in these extracts. This is based on the ®nding that, using an antibody which would recognize all Ubc4 family members, a single Ubc4 peak was identi®ed (not shown) and the sequence of multiple peptides obtained from this band identi®ed only Ubc4. This does not rule out the possibility that the other two family members may be present, but does suggest that Ubc4 predominates. Since Ubc4 appears to be in excess of Ubc3 in the THP.1 extracts it could be utilized as the favored E2 even if it were catalytically less ecient.
These results also demonstrate that the Ubcs are to some degree associated with the SCF complexes in the presence of their substrate, in agreement with previous observations (Mathias et al., 1996; Lisztwan et al., 1998) . This suggests that instead of the transient recruitment of ubiquitin-Ubc to the SCF complex, that the Ubc remains associated, extending the growing ubiquitin chain. These results are consistent with the E3 ligase being composed of a Ubc associated with the SCF complex (Ubc-SCF b-TRCP ) in which the catalytic center is the Ubc. The high M r poly-ubiquitin chains generated by the recombinant SCF b-TRCP complexes are upwards of 40 ubiquitins in length. An interesting question is what controls poly-ubiquitin chain length? It may be that ubiquitination chain length is controlled by some aspect of the enzymatic mechanism of Ubc in the context of the binary complex with SCF. Alternatively, substrates may be degraded before chain elongation ever reaches a limitation of the SCF complex. . As illustrated in Figure 6 , our coupled (i.e., E1, E2, SCF) assay system displays a short lag (*2 min) after which steady state incorporation of ubiquitin into IkBa is observed. The steady state initial velocities for Ubc3 and 4 mediated ubiquitination of IkBa were estimated from the slopes of the steady state phases for these reactions and determined under conditions limiting for the Ubc yet saturating for E1 (not shown). Because the concentrations of E2, ubiquitin, SCF complex and IkBa were similar for the assays utilizing Ubc3 and 4, the initial velocities can be directly related to the relative values of k cat /K m for the two Ubcs (Copeland, 1996) . From this analysis we have determined that the catalytic eciency of the system is *19-fold greater when Ubc4 rather than Ubc3 is used as the E2 component. While we are unable to determine the speci®c activities of Ubc3 and 4 in the THP.1 extracts, the fact that recombinant Ubc4 is more ecient than Ubc3 in IkBa ubiquitination and at least for THP.1 extracts Ubc 4 is in excess to Ubc3 lends strong support to the notion that Ubc4 is the physiologically relevant E2 involved in IkBa poly-ubiquitination.
It has recently been reported that ubiquitination of a phospho-IkBa peptide (aa20 ± 43) by SCF b-TRCP is dependent on Ubc3 and that Ubc4 produced only a mono-ubiquitinated peptide (Vuillard et al., 1999) . We have observed that IkBa in the phospho-IkBa/p50/p65 complex can be mono-ubiquitinated in the presence of E1/Ubc4 alone (Figure 2a, lane 3) but not E1/Ubc3 and that this mono-ubiquitination is not inhibited by the phospho-IkBa p19 peptide (not shown). However, this natural substrate in the presence of SCF b-TRCP is preferentially poly-ubiquitinated in the presence of Ubc4; this dierence may be the result of using a small peptide substrate versus the more natural substrate.
Here we have demonstrated speci®c ubiquitination of IkBa catalyzed by two dierent human Ubcs, Ubc3 and Ubc4, in a reaction requiring the recently identi®ed SCF complex SCF b-TRCP . Using a detailed kinetic analysis we provide evidence that, at least in vitro, Ubc4 is 19 times more ecient than Ubc3 in the ubiquitination of the phospho-IkBa/p50/p65 complex. While this work was being completed, Gonen et al. (1999) published experiments using a partially reconstituted, non-recombinant system that also identi®ed Ubc4/5B, Ubc5C and Ubc3 as the Ubcs involved in IkBa ubiquitination in vitro and provided some data that they are involved in TNFa induced IkBa turnover in cells. Our experiments con®rm and extend these ®ndings to a reconstituted recombinant system and provide compelling evidence that the Ubc donates ubiquitin directly to the substrate IkBa. We also demonstrate that Ubc4 is more ecient at catalyzing this reaction than Ubc3. Finally, we have provided evidence that in lysates from a human cell line both Ubcs are capable of associating with a phospho-IkBa peptide complex containing the SCF b-TRCP . The reconstituted IkBa E3 ligase and phosphorylated ternary complex substrate described here most closely represent a physiologically relevant system and the experiments described identify Ubc4-SCF b-TRCP as the E3 ligase responsible for ubiquitination of IkBa.
Materials and methods

Plasmid and baculovirus construction
Skp1 and Cul1 cDNAs were obtained by PCR and that of Cul3 by hybridization using a partial expressed sequence tag as a probe. The cDNAs encoding b-TRCP and Skp2 were kind gifts from W Harper and H Zhang, respectively. Baculoviral constructs were created using the Fastbac system (Gibco) to create 66-His tagged Cul1 and Cul3 and GST fusions of b-TRCP and Skp2. Skp1 was cloned into the pET15b vector for expression in E. coli as a 66-His fusion protein. The DNA sequences of all constructs were veri®ed using the ABI sequencing system.
Recombinant protein expression and purification
Ubcs were prepared as previously described . His-tagged or GST-tagged proteins were expressed in Sf9 insect cells (1610 6 cells/ml, MOI=5, 72 h) and puri®ed on Ni-agarose (Ni-NTA) (Qiagen) or glutathione sepharose-4B (Pharmacia), respectively, according to the manufacturer. His-Skp1 was expressed in E. coli (BL21-DE3) and puri®ed on Ni-NTA. All recombinant SCF components were dialyzed (6 ± 8 kD M r cut o) into Dialysis Buer containing 25 mM Tris pH 7.5, 10% glycerol, 1 mM dithiothreitol (DTT), 1 mM benzamidine, 0.4 mM PMSF. ) and dialyzed as above. . Rates of IkBa ubiquitination were determined using equal amounts and activities of Ubc3-and 4-SCF b-TRCP as described in the Materials and methods. Results are representative of three individual experiments Q unbound, (120 mg) was titrated to pH 5.0 with 0.5 M MES buer, loaded to Source S (Pharmacia, 1.669 cm) equilibrated in 25 mM (MES), pH 5.0, 1 mM DTT, 1 mM benzamidine, 0.4 mM PMSF and eluted with 20 volumes 0 ± 0.5 M NaCl. Activity was concentrated and loaded (2.2 mg) to S75 gel ®ltration (Pharmacia, 1.0630 cm) equilibrated in POROS HQ buer containing 125 mM NaCl. Activity was loaded (0.14 mg) to mono S 5/5 (Pharmacia) and eluted with a 0 ± 0.5 M NaCl gradient. Coomassie stainable bands (25 ng) from mono S fraction 23 (0.15 M NaCl) were sequenced by the Harvard Microchemistry facility (Cambridge, MA, USA).
Antibodies
Antibodies against the C-terminal peptides to Rbx1 (CPLDNREWEFQKYGH), Ubc3 (CDSGTEES), Ubc4 (CWTQKYAM), full-length human Ubc2 and a GST fusion of the amino terminal 141 residues of Cul3 were generated in rabbits and anity puri®ed. b-TRCP and Cul1 were prepared as described (Winston et al., 1999) ; Skp1 (Transduction Laboratories) and IkBa (Santa Cruz Biotechnology, Inc.) antibodies were purchased.
IkBa ubiquitination assays
Assays were carried out as previously described (Winston et al., 1999) and where indicated contained His-Skp1 (500 nM), His-Cul1 or His-Cul3 (16 nM), GST-b-TRCP or GST-SKP-2 (50 nM). Puri®cation of Q unbound was carried out in assays containing dialyzed and concentrated (106) fraction (10 ml) and Q 0.4 M SCF b-TRCP (50 mg).
Rates of IkBa ubiquitination: Ubc3 vs Ubc4
Rates of IkBa ubiquitination were carried out in assays (15 ml) containing 5 mM ATP-Mg, 1 mM E1, 0.5 mM (0.08 mM active sites, as determined below) His-Ubc3 or 4, 12 nM HisCul1, 12 nM GST-b-TRCP, 3 nM phospho-IkBa/p50/p65, 15 mM biotin-ubiquitin, 200 mM SA-IkBa-p19 (IkBa aa 23-41, S32/36A) or phospho-IkBa-p19 (IkBa aa23-41, S32/ 36phosphorylated), incubated at 258C for times indicated and terminated with 200 ml TBS Casein Blocker (Pierce.). Stopped reactions were loaded to a 96 well Protein G plate (Pierce) plate pre-incubated with Anti-IkBa (Santa Cruz Biotechnology, SC-371, USA), incubated for 1 h at room temperature and washed ®ve times with PBS, 0.1% Tween-20. The amount of biotin-ubiquitin incorporated to IkBa was measured using streptavidin-europium as described by the manufacturer (Wallac) and subtracting phospho-IkBa-p19 counts from SA-IkBa-p19 in order to ensure measurement of only poly-ubiquitinated IkBa. This method ensured the rates of IkBa ubiquitination by Ubc3/4-SCF b-TRCP measured polyubiquitination rather than non-speci®c mono-ubiquitination driven by free Ubc4. These experiments utilized His-Ubc3 and 4 expressed in E. coli puri®ed over nickel agarose and buer exchanged into 25 mM Tris, pH 7.5, 10% glycerol, 0.2 mM DTT. Particulates were removed by centrifugation 25 000 g for 30 min, 48C and stored at 7808C as single use aliquots. Ubc activity was determined by reacting (378C) the Ubc (0.25 mM) with 0.3 mCi 125 I-ubiquitin (Amersham Pharmacia Biotech), 10 mM methylated-ubiquitin (Boston Biochem), 0.2 mM E1, 2.5 mM ATP, 5 mM MgCl 2 . Time points (50 min) were stopped with an equal volume (15 ml) of either 26MES-LDS sample buer (Novex) (non-reducing) or buer containing 700 mM b-mercaptoethanol (reducing). Reduced samples were incubated at 1008C for 5 min. Proteins were separated on 4 ± 12% MES ± SDS Nu-PAGE gels (Novex) and incorporation of 125 I-ubiquitin measured by phospho-imager (Fuji). Active sites were determined by comparing reducing vs non-reducing conditions against a standard curve of 125 I-ubiquitin. His-Ubc3 and 4 incorporated 125 I-ubiquitin at similar rates, which reached saturation at 250 min.
Peptide affinity resins
Phospho-and SA-IkBa-p19 peptide anity sepharose were prepared as previously described (Winston et al., 1999) , blocked with TBS-Casein Blocker (Pierce), 0.1% Tween 20 and washed three times in 3 volumes of TNN buer (Mathias et al., 1996) . THP.1 extracts were added to 125 ml beads (25 mg/ml bead) in 0.5 ml and mixed 1 h at 48C. Beads were washed (361 ml) in 25 mM Tris pH 7.5, protein eluted (5 min, 1008C) with 26Laemmli buer (125 ml), resolved (30 ml) on SDS ± PAGE and revealed by immunodetection. Prior to immunodetection, nitrocellulose was incubated with 62 mM Tris, pH 6.8, 2% SDS, 100 mM b-mercaptoethanol (10 min, 658C) and washed 26with PBS, 0.1% Tween 20 to increase Ubc immunoreactivity.
